Shares of Travere Therapeutics (NASDAQ:TVTX) surged 14% Tuesday following the company's announcement of a successful Type C ...

Biohaven (BHVN) is jumping 10% after the FDA agreed to review the company’s potential treatment for a rare disease.

Inc. has seen its shares tumble to a 52-week low, reaching a price level of just $0.31. According to InvestingPro data, the company's market capitalization has shrunk to just $1.96 million, with ...

Class A shares underperformed the MSCI ACWI ex USA Index. During the quarter, we initiated four new positions and exited one ...

In this piece, we will look at the stocks Jim Cramer recently discussed.

Investing.com -- Shares of Travere Therapeutics, Inc. (NASDAQ: TVTX) rose 7% following the company's announcement of its intent to submit a supplemental New Drug Application (sNDA) for FILSPARI® ...

Incyte has a strong track record of revenue growth and a robust pipeline, targeting over 10 high-impact product launches by ...

Latin Americans would broadly support the use of US military force to oust Venezuelan strongman Nicolás Maduro and take on ...

Viracta, a California biotech oncology firm, is laying off every remaining employee and shutting down after its cash stores ...

Eicher Motors consolidated net profit jumped 17.5% to Rs 1,170.50 crore in Q3 FY25 as compared with Rs 995.97 crore in Q3 FY24. Net sales increased 18.8% YoY to Rs 4,888.11 crore.

Shares of Axsome Therapeutics ( AXSM 20.22%) are flying higher on Monday. The company's stock is up 24.7% as of 1:10 p.m. ET, ...